sacituzumab govitecan
gilead sciences
['mbc', 'sacituzumab govitecan', 'breast']
target expression matters for adcs tropics-2 did not select patients based on trop-2 expression of the breast cancer. hopefully translational work will help unravel how much trop-2 expression matters to the benefit of sacituzumab govitecan in hr+/her2- mbc. #asco2022 
Professor of Translational Oncology and Consultant Medical Oncologist